Literature DB >> 12443893

Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis).

Judith Satoguina1, Martin Mempel, John Larbi, Marlis Badusche, Cornelius Löliger, Ohene Adjei, Gabriel Gachelin, Bernhard Fleischer, Achim Hoerauf.   

Abstract

Different mechanisms underlie the phenomenon of peripheral tolerance. Recently, a new subset of CD4+ T cells, called T regulatory-1 (Tr1) cells, was described which show suppressor functions in vitro and in vivo and are characterized by a predominant production of IL-10 and/or TGF-beta. Tr1 cells have so far been generated experimentally in an IL-10-rich environment and hold promise for exploitation in the suppression of alloreactions and inflammatory or allergic dispositions. However, these cells have not been characterized in infectious diseases. Here we show that in the chronic helminth infection onchocerciasis (river blindness), where patients have relatively little sign of dermatitis despite the presence of millions of small worms in the skin, T cells can be obtained which bear characteristics of Tr1 cells, producing no IL-2 or IL-4 but substantial amounts of IL-10, variable amounts of IL-5, and some IFN-gamma. These cells display elevated amounts of CTLA-4 after stimulation and are able to inhibit other T cells in coculture, in contrast to Th1 and Th2 clones. This is the first time that this type of suppressor T cell has been cloned as naturally occurring during an infectious disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443893     DOI: 10.1016/s1286-4579(02)00014-x

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  63 in total

Review 1.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 2.  Will worms really cure Crohn's disease?

Authors:  G L Radford-Smith
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 3.  Regulatory T cells in human disease and their potential for therapeutic manipulation.

Authors:  Leonie S Taams; Donald B Palmer; Arne N Akbar; Douglas S Robinson; Zarin Brown; Catherine M Hawrylowicz
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 4.  Natural regulatory T cells in autoimmunity.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Autoimmunity       Date:  2010-11-23       Impact factor: 2.815

Review 5.  Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature.

Authors:  Natasha-A Koloski; Laurel Bret; Graham Radford-Smith
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

6.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 7.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 8.  Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review.

Authors:  Rada Miskovic; Aleksandra Plavsic; Jasna Bolpacic; Sanvila Raskovic; Jovan Ranin; Mirjana Bogic
Journal:  Rheumatol Int       Date:  2018-10-23       Impact factor: 2.631

Review 9.  Chronic helminth infections protect against allergic diseases by active regulatory processes.

Authors:  Hermelijn H Smits; Bart Everts; Franca C Hartgers; Maria Yazdanbakhsh
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

10.  Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.

Authors:  Tarik Attout; Achim Hoerauf; Gaëlle Dénécé; Alexander Yaw Debrah; Yeboah Marfo-Debrekyei; Michel Boussinesq; Samuel Wanji; Valérie Martinez; Sabine Mand; Ohene Adjei; Odile Bain; Sabine Specht; Coralie Martin
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.